Chemomab Therapeutics Market Sentiment

Chemomab Therapeutics Ltd

CMMBNASDAQ

$1.25

-0.04-3.1%

마지막 업데이트: Oct 16, 3:59 PM

Chemomab Therapeutics Market Sentiment - Benzinga

Market sentiment signals for Chemomab Therapeutics (CMMB): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▲ 0.1% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

3 analysts

Options Flow (P/C)

—

Avg Consensus PT

$27

+2034.4%

Highest Price Target

$28

+2113.4%

Roth MKM

Lowest Price Target

$25

+1876.3%

Oppenheimer

Short Interest

0.1%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 27, 2025	Oppenheimer	Jeff Jones—	+1876.3%	$10 → $25	Maintained	Outperform
May 16, 2025	Oppenheimer	Jeff Jones—	+690.5%	$11 → $10	Maintained	Outperform
Feb 20, 2025	Maxim Group	Michael Okunewitch—	+453.4%	$4 → $7	Maintained	Buy
Nov 15, 2024	Oppenheimer	Jeff Jones—	+769.6%	$13 → $11	Maintained	Outperform
May 13, 2024	Maxim Group	Michael Okunewitch—	+216.2%	$4	Initiate	Buy
May 6, 2024	Oppenheimer	Jeff Jones—	+374.3%	$6	Upgrade	Perform→Outperform
Mar 8, 2024	Oppenheimer	Jeff Jones—	—	—	Maintained	Perform
Dec 19, 2023	Roth MKM	Dylan Dupuis—	+453.4%	$7 → $7	Reinstates	Buy